527 related articles for article (PubMed ID: 28663326)
21. Clinical significance of anti-Ro52 (TRIM21) antibodies non-associated with anti-SSA 60kDa antibodies: results of a multicentric study.
Ghillani P; André C; Toly C; Rouquette AM; Bengoufa D; Nicaise P; Goulvestre C; Gleizes A; Dragon-Durey MA; Alyanakian MA; Chretien P; Chollet-Martin S; Musset L; Weill B; Johanet C
Autoimmun Rev; 2011 Jul; 10(9):509-13. PubMed ID: 21447407
[TBL] [Abstract][Full Text] [Related]
22. Clinical Significance of Different Profiles of anti-Ro Antibodies in Connective Tissue Diseases.
Yang HT; Hong XP; Guo JW; Zhong XL; Liao R; Liu CL; Liu LX; Li K; Chen YL; Liu DZ
J Immunol Res; 2023; 2023():9195157. PubMed ID: 36741231
[TBL] [Abstract][Full Text] [Related]
23. Two subgroups in systemic lupus erythematosus with features of antiphospholipid or Sjögren's syndrome differ in molecular signatures and treatment perspectives.
Idborg H; Zandian A; Sandberg AS; Nilsson B; Elvin K; Truedsson L; Sohrabian A; Rönnelid J; Mo J; Grosso G; Kvarnström M; Gunnarsson I; Lehtiö J; Nilsson P; Svenungsson E; Jakobsson PJ
Arthritis Res Ther; 2019 Feb; 21(1):62. PubMed ID: 30777133
[TBL] [Abstract][Full Text] [Related]
24. Calreticulin binds preferentially with B cell linear epitopes of Ro60 kD autoantigen, enhancing recognition by anti-Ro60 kD autoantibodies.
Staikou EV; Routsias JG; Makri AA; Terzoglou A; Sakarellos-Daitsiotis M; Sakarellos C; Panayotou G; Moutsopoulos HM; Tzioufas AG
Clin Exp Immunol; 2003 Oct; 134(1):143-50. PubMed ID: 12974767
[TBL] [Abstract][Full Text] [Related]
25. Anti-Ro60 Seropositivity Determines Anti-Ro52 Epitope Mapping in Patients With Systemic Sclerosis.
Gkoutzourelas A; Liaskos C; Mytilinaiou MG; Simopoulou T; Katsiari C; Tsirogianni A; Daoussis D; Scheper T; Meyer W; Bogdanos DP; Sakkas LI
Front Immunol; 2018; 9():2835. PubMed ID: 30581434
[TBL] [Abstract][Full Text] [Related]
26. Autoantibodies to Cytosolic 5'-Nucleotidase 1A in Primary Sjögren's Syndrome and Systemic Lupus Erythematosus.
Rietveld A; van den Hoogen LL; Bizzaro N; Blokland SLM; Dähnrich C; Gottenberg JE; Houen G; Johannsen N; Mandl T; Meyer A; Nielsen CT; Olsson P; van Roon J; Schlumberger W; van Engelen BGM; Saris CGJ; Pruijn GJM
Front Immunol; 2018; 9():1200. PubMed ID: 29922285
[TBL] [Abstract][Full Text] [Related]
27. Anti-Ro52/TRIM21 serological subsets identify differential clinical and laboratory parameters.
Lee AYS; Lin MW; Reed JH
Clin Rheumatol; 2022 Nov; 41(11):3495-3501. PubMed ID: 35871174
[TBL] [Abstract][Full Text] [Related]
28. Latest update on the Ro/SS-A autoantibody system.
Schulte-Pelkum J; Fritzler M; Mahler M
Autoimmun Rev; 2009 Jun; 8(7):632-7. PubMed ID: 19393201
[TBL] [Abstract][Full Text] [Related]
29. Subcellular redistribution and surface exposure of the Ro52, Ro60 and La48 autoantigens during apoptosis in human ductal epithelial cells: a possible mechanism in the pathogenesis of Sjögren's syndrome.
Ohlsson M; Jonsson R; Brokstad KA
Scand J Immunol; 2002 Nov; 56(5):456-69. PubMed ID: 12410795
[TBL] [Abstract][Full Text] [Related]
30. Clinical and laboratory aspects of Ro/SSA-52 autoantibodies.
Defendenti C; Atzeni F; Spina MF; Grosso S; Cereda A; Guercilena G; Bollani S; Saibeni S; Puttini PS
Autoimmun Rev; 2011 Jan; 10(3):150-4. PubMed ID: 20854935
[TBL] [Abstract][Full Text] [Related]
31. Sera from patients with rheumatic diseases recognize different epitope regions on the 52-kD Ro/SS-A protein.
Bozic B; Pruijn GJ; Rozman B; van Venrooij WJ
Clin Exp Immunol; 1993 Nov; 94(2):227-35. PubMed ID: 7693382
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic utility of anti-Ro52 detection in systemic autoimmunity.
Dugar M; Cox S; Limaye V; Gordon TP; Roberts-Thomson PJ
Postgrad Med J; 2010 Feb; 86(1012):79-82. PubMed ID: 20145055
[TBL] [Abstract][Full Text] [Related]
33. Anti-Ro52 antibody testing influences the classification and clinical characterisation of primary Sjögren's syndrome.
Retamozo S; Akasbi M; Brito-Zerón P; Bosch X; Bove A; Perez-de-Lis M; Jimenez I; Soto-Cardenas MJ; Gandia M; Diaz-Lagares C; Viñas O; Siso A; Perez-Alvarez R; Yague J; Ramos-Casals M
Clin Exp Rheumatol; 2012; 30(5):686-92. PubMed ID: 22704838
[TBL] [Abstract][Full Text] [Related]
34. The prevalence and the clinical relevance of anti-Ro52 in Korean patients with primary Sjögren's syndrome.
Song JS; Do JH; Lee SW
Rheumatol Int; 2012 Feb; 32(2):491-5. PubMed ID: 21246358
[TBL] [Abstract][Full Text] [Related]
35. Role of autoantibodies to various Ro60 epitopes in the decrease of lymphocytes seen in systemic lupus erythematosus and primary Sjögren's syndrome.
Shuai ZW; Huang Y; Zhang L; Cai J; Li M
Genet Mol Res; 2015 Aug; 14(3):10096-102. PubMed ID: 26345947
[TBL] [Abstract][Full Text] [Related]
36. The 52 000 MW Ro/SS-A autoantigen in Sjögren's syndrome/systemic lupus erythematosus (Ro52) is an interferon-gamma inducible tripartite motif protein associated with membrane proximal structures.
Rhodes DA; Ihrke G; Reinicke AT; Malcherek G; Towey M; Isenberg DA; Trowsdale J
Immunology; 2002 Jun; 106(2):246-56. PubMed ID: 12047754
[TBL] [Abstract][Full Text] [Related]
37. Anti-SSA Ro52 and anti-Ro60 autoantibodies: association with clinical phenotypes.
Mazeda C; Oliveira N; Abreu C; Fraga V; Maduro I; Saraiva A; Inês L; Ferreira C; Correia AM; Nicolau R; Farinha F; Villanueva I; Jesus D; Abreu P; Neto A; Silva Dinis J; Barcelos A
Clin Exp Rheumatol; 2024 Mar; ():. PubMed ID: 38530658
[TBL] [Abstract][Full Text] [Related]
38. Anti-Ro60 and anti-Ro52/TRIM21: Two distinct autoantibodies in systemic autoimmune diseases.
Lee AYS; Reed JH; Gordon TP
J Autoimmun; 2021 Nov; 124():102724. PubMed ID: 34464814
[TBL] [Abstract][Full Text] [Related]
39. Epitope mapping with synthetic peptides of 52-kD SSA/Ro protein reveals heterogeneous antibody profiles in human autoimmune sera.
Ricchiuti V; Briand JP; Meyer O; Isenberg DA; Pruijn G; Muller S
Clin Exp Immunol; 1994 Mar; 95(3):397-407. PubMed ID: 7511075
[TBL] [Abstract][Full Text] [Related]
40. Cross-reaction between antibodies to the major epitope of Ro60 kD autoantigen and a homologous peptide of Coxsackie virus 2B protein.
Stathopoulou EA; Routsias JG; Stea EA; Moutsopoulos HM; Tzioufas AG
Clin Exp Immunol; 2005 Jul; 141(1):148-54. PubMed ID: 15958081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
